Abstract
Dermatomyositis (DM) and polymyositis (PM) are rare systemic idiopathic inflammatory myopathies associated with high morbidity and functional disability. DM/PM patients may show as clinical consequence, increased muscle atrophy/hypotrophy associated with decreased muscle oxidative capacity. In addition, our group showed for the first time that DM/PM patients have a high prevalence of meta…